Benefits And Science

Fisetin raised seizure thresholds and slowed kindling in rodent epilepsy models. It has never been tested in people with epilepsy. Here is the evidence.

Fisetin calmed psoriasis-like and eczema-like skin inflammation in lab skin and mice, mostly applied to the skin. No patient trial exists. Here is the evidence.

In mice with allergic asthma, fisetin calmed airway inflammation and twitchy airways. No person with asthma has been studied. Here is what the research shows.

Fisetin killed prostate cancer cells and boosted cabazitaxel in mice. No trial has tested it in men. Here is what the lab studies found.

Fisetin slowed melanoma cells and tumours in mice, alone and alongside sorafenib. It has never been tested in melanoma patients. Here is the evidence.

Fisetin reduced artery plaque and lowered cholesterol in mice bred to develop atherosclerosis. No human trial has tested it. Here is what the studies show.

Fisetin relaxed arteries and lowered blood pressure in hypertensive rats. No human trial has tested it. Here is what the animal studies show.

A 2024 Aging Cell study counted senescent white blood cells with C12FDG. The count rose with age and fell in a small group taking fisetin.

Two 2026 trials tested fisetin with resistance training in men with obesity. The results are real, and the two papers are almost certainly one study.

A double-blind trial gave fisetin to colorectal cancer patients during chemotherapy. Read carefully, it found less than it is usually cited as finding.

Search for fisetin and arthritis and you will get results about joint pain, cartilage and senescent cells. Almost all of

Most fisetin human research is small, short, and aimed at slow outcomes such as frailty or biological age. There is